Looking into the Future: Moving Towards Non-Viral Gene Therapies
Time: 10:00 am
day: Conference Day Two
Details:
- Overview of Vesigen Therapeutics’ ARMMS technology as a novel modality for non-viral delivery of therapeutics
- Managing scalable upstream production of ARMMs using transient transfection or stable producer cell lines
- Exploring the advantages of ARMMs as a delivery platform for gene therapies
